Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
Healthcare Reimbursement Market: By Claim, By Payers, By Service Provider and By Region Forecast 2019-2030
Healthcare Reimbursement Market size was valued at US$ 22.3 billion by 2023 and is poised to grow at a CAGR of 19.2% from 2024-2030 owing to an increase in the prevalence of chronic diseases, rising patient population, support by the government along with the rising cost of prescription medications are the major factors that are driving the growth of the market.
Moreover, initiatives by the public and private entities and growing awareness among people about healthcare insurance policies fuel the growth of the market over the forecast period. The payment that your hospital, doctor, diagnostic facility, or other healthcare providers receive for providing you with medical services is referred to as healthcare reimbursement. Often, your health insurer or a government payer will cover all or part of the cost of your medical treatment. The market's key growth drivers have been the growing healthcare burden on established and developing economies, as well as good regulatory regulations and a favorable reimbursement scenario.
The research makes a spectacular endeavor to disclose important opportunities available in the worldwide market to help players achieve a strong market position, with industry-standard precision in analysis and high data integrity. The report's buyers will have access to validated and trustworthy market forecasts, such as those for the worldwide market's overall revenue size. Overall, the report demonstrates that players may utilize it to acquire a competitive advantage over their competitors and achieve long-term success in the worldwide market. With the support of reliable sources, all of the report's results, data, and information are validated and revalidated. For an in-depth examination of the worldwide Healthcare market, the analysts who prepared the report used a unique and industry-best research and analysis approach.
Study Period
2024-2030Base Year
2023CAGR
19.2%Largest Market
North AmericaFastest Growing Market
Asia-Pacific
The center for Medicare and Medicaid Services offers delivery of reliable high-quality care, endorsement of efficient results in healthcare systems and making health insurance available to millions of Americans. In 2016, the Medicaid spending in U.S. grew by 3.9% and Medicare spending grew by 3.6% that was equal to 20% of total National Health Expenditure. The underpaid segment is expected dominate the healthcare reimbursement market over the forecast years due to increasing cases of frauds against government healthcare programs and rising use of healthcare services that are not medically required. There are number of cases where business and individuals have defrauded federal and state government healthcare programs by submitting the false claims for healthcare services, treatment and medical devices that were never rendered.
Report Benchmarks |
Details |
Report Study Period |
2024-2030 |
Market Size in 2023 |
US$ 22.3 billion |
Market CAGR |
19.2% |
By Claim |
|
By Payers |
|
By Service Providers |
|
By Region |
|
Download Free Sample Report
The healthcare reimbursement market size was valued at US$ 22.3 billion in 2023 and is set to grow at a significant CAGR of 19.2% from 2024-2030.
The market key players are: UnitedHealth Group CVS Health Aetna Inc. WellCare Health Plans, Inc. BNP Paribas Aviva Life Insurance Company India Ltd. Reliance Nippon Life Insurance Company Limited Agile Health Insurance Blue Cross Blue Shield Association. Allianz
The market has been classified into North America, Asia Pacific, Europe, Latin America, Middle East and Africa, and the rest of MEA.
1. Executive Summary |
2. Global Healthcare Reimbursement Market Introduction |
2.1.Global Healthcare Reimbursement Market - Taxonomy |
2.2.Global Healthcare Reimbursement Market - Definitions |
2.2.1.Claim |
2.2.2.Payers |
2.2.3. Service Providers |
2.2.4.Region |
3. Global Healthcare Reimbursement Market Dynamics |
3.1. Drivers |
3.2. Restraints |
3.3. Opportunities/Unmet Needs of the Market |
3.4. Trends |
3.5. Product Landscape |
3.6. New Product Launches |
3.7. Impact of COVID 19 on Market |
4. Global Healthcare Reimbursement Market Analysis, 2019 - 2023 and Forecast 2024 - 2030 |
4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
4.3. Market Opportunity Analysis |
5. Global Healthcare Reimbursement Market By Claim, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
5.1. Underpaid |
5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.3. Market Opportunity Analysis |
5.2. Full Paid |
5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.3. Market Opportunity Analysis |
6. Global Healthcare Reimbursement Market By Payers, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
6.1. Private Payers |
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.1.3. Market Opportunity Analysis |
6.2. Public Payers |
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.2.3. Market Opportunity Analysis |
7. Global Healthcare Reimbursement Market By Service Providers, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
7.1. Hospitals |
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.1.3. Market Opportunity Analysis |
7.2. Clinics |
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.2.3. Market Opportunity Analysis |
7.3. Diagnostic Laboratories |
7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.3.3. Market Opportunity Analysis |
7.4. Others |
7.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.4.3. Market Opportunity Analysis |
8. Global Healthcare Reimbursement Market By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
8.1. North America |
8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.1.3. Market Opportunity Analysis |
8.2. Europe |
8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.2.3. Market Opportunity Analysis |
8.3. Asia Pacific (APAC) |
8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.3.3. Market Opportunity Analysis |
8.4. Middle East and Africa (MEA) |
8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.4.3. Market Opportunity Analysis |
8.5. Latin America |
8.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.5.3. Market Opportunity Analysis |
9. North America Healthcare Reimbursement Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
9.1. Claim Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.1.1.Underpaid |
9.1.2.Full Paid |
9.2. Payers Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.2.1.Private Payers |
9.2.2.Public Payers |
9.3. Service Providers Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.3.1.Hospitals |
9.3.2.Clinics |
9.3.3.Diagnostic Laboratories |
9.3.4.Others |
9.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.4.1.United States of America (USA) |
9.4.2.Canada |
10. Europe Healthcare Reimbursement Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
10.1. Claim Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.1.1.Underpaid |
10.1.2.Full Paid |
10.2. Payers Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.2.1.Private Payers |
10.2.2.Public Payers |
10.3. Service Providers Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.3.1.Hospitals |
10.3.2.Clinics |
10.3.3.Diagnostic Laboratories |
10.3.4.Others |
10.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.4.1.Germany |
10.4.2.France |
10.4.3.Italy |
10.4.4.United Kingdom (UK) |
10.4.5.Spain |
10.4.6.Rest of EU |
11. Asia Pacific (APAC) Healthcare Reimbursement Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
11.1. Claim Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.1.1.Underpaid |
11.1.2.Full Paid |
11.2. Payers Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.2.1.Private Payers |
11.2.2.Public Payers |
11.3. Service Providers Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.3.1.Hospitals |
11.3.2.Clinics |
11.3.3.Diagnostic Laboratories |
11.3.4.Others |
11.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.4.1.China |
11.4.2.India |
11.4.3.Australia and New Zealand (ANZ) |
11.4.4.Japan |
11.4.5.Rest of APAC |
12. Middle East and Africa (MEA) Healthcare Reimbursement Market,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
12.1. Claim Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.1.1.Underpaid |
12.1.2.Full Paid |
12.2. Payers Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.2.1.Private Payers |
12.2.2.Public Payers |
12.3. Service Providers Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.3.1.Hospitals |
12.3.2.Clinics |
12.3.3.Diagnostic Laboratories |
12.3.4.Others |
12.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.4.1.GCC Countries |
12.4.2.South Africa |
12.4.3.Rest of MEA |
13. Latin America Healthcare Reimbursement Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
13.1. Claim Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.1.1.Underpaid |
13.1.2.Full Paid |
13.2. Payers Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.2.1.Private Payers |
13.2.2.Public Payers |
13.3. Service Providers Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.3.1.Hospitals |
13.3.2.Clinics |
13.3.3.Diagnostic Laboratories |
13.3.4.Others |
13.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.4.1.Brazil |
13.4.2.Mexico |
13.4.3.Rest of LA |
14. Competition Landscape |
14.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M&A, Strategies, and SWOT Analysis) |
14.2.1.UnitedHealth Group |
14.2.2.CVS Health |
14.2.3.Aetna Inc. |
14.2.4.WellCare Health Plans, Inc. |
14.2.5.BNP Paribas |
14.2.6.Aviva Life Insurance Company India Ltd. |
14.2.7.Reliance Nippon Life Insurance Company Limited |
14.2.8.Agile Health Insurance |
14.2.9.Blue Cross Blue Shield Association. |
14.2.10.Allianz |
15. Research Methodology |
16. Appendix and Abbreviations |
Key Market Players